Mitsubishi UFJ Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $50.4M | Buy |
152,197
+13,402
| +10% | +$4.56M | 0.03% | 374 |
|
|
2025
Q4 | $55.5M | Buy |
138,795
+18,008
| +15% | +$7.97M | 0.04% | 341 |
|
|
2025
Q3 | $55.1M | Buy |
120,787
+9,002
| +8% | +$3.67M | 0.04% | 333 |
|
|
2025
Q2 | $36.5M | Buy |
111,785
+5,906
| +6% | +$1.63M | 0.03% | 410 |
|
|
2025
Q1 | $28.6M | Buy |
105,879
+11,181
| +12% | +$2.87M | 0.03% | 437 |
|
|
2024
Q4 | $22.2M | Buy |
94,698
+9,393
| +11% | +$2.47M | 0.02% | 479 |
|
|
2024
Q3 | $23.5M | Buy |
85,305
+6,744
| +9% | +$1.76M | 0.03% | 450 |
|
|
2024
Q2 | $19.1M | Buy |
78,561
+9,771
| +14% | +$1.54M | 0.02% | 453 |
|
|
2024
Q1 | $10.3M | Buy |
68,790
+12,646
| +23% | +$2.11M | 0.01% | 536 |
|
|
2023
Q4 | $10.7M | Buy |
56,144
+3,665
| +7% | +$624K | 0.02% | 501 |
|
|
2023
Q3 | $9.29M | Buy |
52,479
+5,980
| +13% | +$1.14M | 0.02% | 500 |
|
|
2023
Q2 | $8.83M | Buy |
46,499
+2,609
| +6% | +$517K | 0.02% | 509 |
|
|
2023
Q1 | $8.79M | Buy |
43,890
+3,421
| +8% | +$719K | 0.02% | 494 |
|
|
2022
Q4 | $9.45M | Buy |
40,469
+3,269
| +9% | +$697K | 0.03% | 452 |
|
|
2022
Q3 | $7.45M | Buy |
37,200
+2,825
| +8% | +$539K | 0.02% | 470 |
|
|
2022
Q2 | $5.01M | Buy |
34,375
+2,738
| +9% | +$388K | 0.02% | 542 |
|
|
2022
Q1 | $5.17M | Buy |
31,637
+1,918
| +6% | +$292K | 0.02% | 567 |
|
|
2021
Q4 | $5.17M | Buy |
29,719
+1,087
| +4% | +$202K | 0.02% | 580 |
|
|
2021
Q3 | $5.41M | Sell |
28,632
-273
| -0.9% | -$51.2K | 0.03% | 550 |
|
|
2021
Q2 | $4.9M | Buy |
28,905
+1,210
| +4% | +$177K | 0.03% | 565 |
|
|
2021
Q1 | $3.91M | Buy |
27,695
+3,207
| +13% | +$483K | 0.03% | 568 |
|
|
2020
Q4 | $3.18M | Buy |
24,488
+853
| +4% | +$114K | 0.02% | 551 |
|
|
2020
Q3 | $3.44M | Buy |
23,635
+3,762
| +19% | +$535K | 0.03% | 462 |
|
|
2020
Q2 | $2.94M | Buy |
19,873
+1,939
| +11% | +$261K | 0.03% | 437 |
|
|
2020
Q1 | $1.95M | Sell |
17,934
-1,933
| -10% | -$223K | 0.03% | 460 |
|
|
2019
Q4 | $2.3M | Buy |
19,867
+3,135
| +19% | +$313K | 0.03% | 499 |
|
|
2019
Q3 | $1.35M | Buy |
16,732
+2,063
| +14% | +$163K | 0.02% | 556 |
|
|
2019
Q2 | $1.06M | Buy |
14,669
+1,011
| +7% | +$77.6K | 0.02% | 621 |
|
|
2019
Q1 | $1.28M | Buy |
13,658
+1,392
| +11% | +$116K | 0.03% | 510 |
|
|
2018
Q4 | $898K | Sell |
12,266
-1,083
| -8% | -$83.3K | 0.02% | 555 |
|
|
2018
Q3 | $1.17M | Buy |
13,349
+2,248
| +20% | +$226K | 0.02% | 563 |
|
|
2018
Q2 | $1.09M | Sell |
11,101
-624
| -5% | -$61.9K | 0.02% | 560 |
|
|
2018
Q1 | $1.4M | Sell |
11,725
-673
| -5% | -$86.8K | 0.03% | 485 |
|
|
2017
Q4 | $1.67M | Buy |
12,398
+11,661
| +1,582% | +$1.47M | 0.04% | 469 |
|
|
2017
Q3 | $87K | Sell |
737
-48
| -6% | -$4.1K | ﹤0.01% | 790 |
|
|
2017
Q2 | $63K | Sell |
785
-45
| -5% | -$2.88K | ﹤0.01% | 803 |
|
|
2017
Q1 | $43K | Sell |
830
-98
| -11% | -$4.53K | ﹤0.01% | 817 |
|
|
2016
Q4 | $36K | Sell |
928
-11,024
| -92% | -$462K | ﹤0.01% | 819 |
|
|
2016
Q3 | $810K | Buy |
11,952
+184
| +2% | +$13K | 0.02% | 610 |
|
|
2016
Q2 | $653K | Buy |
11,768
+266
| +2% | +$16.8K | 0.02% | 639 |
|
|
2016
Q1 | $722K | Buy |
11,502
+1,989
| +21% | +$132K | 0.02% | 608 |
|
|
2015
Q4 | $896K | Buy |
9,513
+680
| +8% | +$63K | 0.03% | 554 |
|
|
2015
Q3 | $710K | Sell |
8,833
-156
| -2% | -$17.3K | 0.02% | 593 |
|
|
2015
Q2 | $1.08M | Buy |
+8,989
| New | +$1.07M | 0.03% | 524 |
|
Other funds holding ALNY
VPM
VCM
